PA) - Raymond S. Roginski, MD, PhD, has been
appointed Assistant Professor in the Department of Anesthesia
at the University of Pennsylvania School of Medicine.
Dr. Roginski attended Yale University, where he earned
his BS and MS degrees in Molecular Biophysics and Biochemistry.
He went on to receive another MS, his MD and PhD from
the Albert Einstein College of Medicine of Yeshiva University.
He performed his internship and residency in Anesthesiology
at Albert Einstein Affiliated Hospitals in the Bronx,
New York. Dr. Roginski was an Associate Professor of
Anesthesia at the University of Medicine and Dentistry
of New Jersey (UMDNJ)-Robert Wood Johnson Medical School,
before joining Penn.
Dr. Roginski's research focuses on perioperative neuroprotection
and neurodegenerative diseases, including autism. His
Anesthesia interests include invasive neuroradiology,
cardiology, ENT (ear, nose & throat), urologic surgery,
day surgery and resident teaching. While at UMDNJ-Robert
Wood Johnson Medical School, he discovered and mapped
a pair of glutamate receptor-like genes named GRINL1A
(chromosome 15) and GRINL1B (chromosome 4) in humans.
He and his colleagues have also found these genes in
rats and mice. At Penn, he continues to investigate
the function of these genes and their role in neuroprotection
and/or autism. To support his research, he has received
funding from the Foundation for Anesthesia Education
and Research, the American Cancer Society, the National
Science Foundation, the Foundation for the University
of Medicine and Dentistry of New Jersey, and the New
Jersey Governor's Council on Autism.
He is a member of the American Society of Anesthesiologists,
the Society of Neurosurgical Anesthesia and Critical
Care, the International Anesthesia Research Society
and the Society for Neuroscience. His research has been
published in several journals including Cell, Molecular
Cell Biology, Cytogenetics and Cell Genetics, Proceedings
of the National Academy of Sciences, Federation of European
Biochemical Societies (FEBS) Letters and Anesthesia
Clinics of North America.
# # #
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.